NCT05218655Phase 3Completed

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Study sponsor: PTC Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-04-15Actual
Enrollment · participants101Actual
Source updated2025-12-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Actual enrollment decreased by 1 participants

Before: 102 participants (actual). After: 101 participants (actual).

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Number of Participants With Adverse Events (AEs). After: Measure: Number of Participants With Treatment-emergent Adverse Events (TEAEs).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview